is a Little Big Town biopharmaceutical company

Posted by Admin· Print This Article

is a shares boondock little big town biopharmaceutical company recounts focused ondeveloping innovative non-antibiotic, antimicrobial product candidates targetingthe treatment or prevention of a wide range of infections in hospital andnon-hospital environments. NovaBay has discovered and is developing a class ofnon-antibiotic anti-infective compounds, which it has named Aganocide compounds,which are based upon small molecules that are generated by white blood cellsthat defend the body against invading pathogens, without ever developingresistance. NovaBay believes that Aganocide compounds could form a platform onwhich to create a variety of products to address differing needs in thetreatment and prevention of bacterial and viral infections, including resistantbacteria such as MRSA. NovaBay has entered into a licensing and researchcollaboration agreement with an affiliate of Alcon, Inc. for use of theAganocide compounds in the eye, ear and sinus, and in contact lens solutions. NovaBay® and Aganocide® are trademarks of NovaBay Pharmaceuticals, Inc.

Allother trademarks and trade names are the property of their respective owners boondox little big town . Forward-Looking StatementsThis release contains forward-looking statements within the meaning of the "safeharbor" provisions of the Private Securities Litigation Reform Act of 1995,based upon management`s current expectations, assumptions, estimates,projections and beliefs . These forward-looking statements can often beidentified by words such as "expects", "intends", "plans", "believes","estimates", "may", "will", and similar expressions, and variations or negativesof these words . These statements include, but are not limited to, statementsregarding the development and potential benefits of, and the marketopportunities for, or the potential commercialization of NovaBay`s productcandidates, as well as the timing of any such development or commercialization.Forward-looking statements involve known and unknown risks, uncertainties andother factors that may cause actual results or achievements to be materiallydifferent and adverse from those expressed in or implied by the forward-lookingstatements .

Factors that might cause or contribute to such differences include,but are not limited to, risks and uncertainties relating to difficulties ordelays in discovery, development, testing, regulatory approval, production andmarketing of the company`s product candidates, unexpected adverse side effectsor inadequate therapeutic efficacy of the product candidates, the uncertainty ofpatent protection for the company`s intellectual property or trade secrets, thecompany`s ability to obtain additional financing as necessary and unanticipatedresearch and development and other costs and other risks detailed from time totime in NovaBay`s filings with the Securities and Exchange Commission includingthe annual report on Form 10-K for the year ended December 31, 2007 little big town boondocks . Theforward-looking statements in this release speak only as of this date, andNovaBay disclaims any intent or obligation to revise or update publicly anyforward-looking statement except as required by law . NovaBay Pharmaceuticals, Inc.Investor Relations:Theresa Granados, 510-899-8870Head of Investor orThe Investor Relations GroupInvestor Relations:Adam Holdsworth / James CarbonaraMedia Relations:Janet Vasquez / Laura Colontrelle212-825-3210 Copyright Business Wire 2009 . TORONTO, Jan 09 (MARKET WIRE) -- Element 21 Golf Company (OTCBB: ETGF) (FRANKFURT: BJQ), the leadingmanufacturer of advanced Scandium Alloy golf and fishing equipment,announced today that Acorn Research has issued a research report with atarget 12 months stock price of $3.10 .

The report is available on line at(ETGF).pfElement 21 Sports Company is a vertically integrated Scandium metalcompany that produces golf and fishing equipment made with proprietarytechnology and patented Element 21 metal . The objective of Element 21Sports is to position the organization as a key innovator in the retailgolf and fishing equipment market . Element 21 Sports Company plans toexpand its product lines to include hockey, baseball, cycling, tennis,and other sports, where strength and lightness is required to improveperformance and playability.Element 21 Sports Company's premier products are golf clubs and fishingpoles made out of a Scandium and biofiber materials, which are light,durable, and long-lasting . Element 21's golf clubs have been used byrenowned golf pros, such as the winner of the FedEx Cup in 2008, whocontinue to use Element 21's Scandium technology during professionalcompetition .